LifeStance Health Group, Inc. (LFST) stock
LFSTNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/30146% above fair value
$14.15−0.22 (-1.53%)
Close on Nov 12, 2026Market cap $5.41BP/E 74.5Yield –
LifeStance Health total assets
Total assets on the balance sheet at the end of each period.
LifeStance Health's total assets was $2.19B at Sep 30, 2026. For fiscal 2025 it was $2.20B, up 4.0% from the year before. The highest annual figure on record is $2.20B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.20B | +4.0% |
| FY2024 | Dec 31, 2024 | $2.12B | +0.4% |
| FY2023 | Dec 31, 2023 | $2.11B | -2.9% |
| FY2022 | Dec 31, 2022 | $2.17B | +12.8% |
| FY2021 | Dec 31, 2021 | $1.93B | +22.8% |
| FY2020 | Dec 31, 2020 | $1.57B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.19B | +1.7% |
| Q2 FY2026 | Jun 30, 2026 | $2.18B | +1.6% |
| Q1 FY2026 | Mar 31, 2026 | $2.15B | +2.0% |
| Q4 FY2025 | Dec 31, 2025 | $2.20B | +4.0% |
| Q3 FY2025 | Sep 30, 2025 | $2.15B | +1.9% |
| Q2 FY2025 | Jun 30, 2025 | $2.15B | +1.3% |
| Q1 FY2025 | Mar 31, 2025 | $2.10B | -0.1% |
| Q4 FY2024 | Dec 31, 2024 | $2.12B | +0.4% |
| Q3 FY2024 | Sep 30, 2024 | $2.11B | -3.1% |
| Q2 FY2024 | Jun 30, 2024 | $2.12B | -2.4% |
| Q1 FY2024 | Mar 31, 2024 | $2.11B | -2.4% |
| Q4 FY2023 | Dec 31, 2023 | $2.11B | -2.9% |
| Q3 FY2023 | Sep 30, 2023 | $2.18B | +9.9% |
| Q2 FY2023 | Jun 30, 2023 | $2.17B | +10.3% |
| Q1 FY2023 | Mar 31, 2023 | $2.16B | +10.2% |
| Q4 FY2022 | Dec 31, 2022 | $2.17B | +12.8% |
| Q3 FY2022 | Sep 30, 2022 | $1.98B | +3.4% |
| Q2 FY2022 | Jun 30, 2022 | $1.97B | +2.8% |
| Q1 FY2022 | Mar 31, 2022 | $1.96B | +24.8% |
| Q4 FY2021 | Dec 31, 2021 | $1.93B | – |
| Q3 FY2021 | Sep 30, 2021 | $1.91B | – |
| Q2 FY2021 | Jun 30, 2021 | $1.91B | – |
| Q4 FY2020 | Dec 31, 2020 | $1.57B | – |
See a number that looks wrong?